“By pursuing clinical trials in foreign countries with lower standards and where F.D.A. lacks oversight, the industry is seeking the path of least resistance toward lower costs and higher profits to the detriment of public health.”
Full New York Times article found here
Author: Rossa Forbes
I’m a mom walking the long road of recovery alongside my son, whose world shifted at nineteen with a schizophrenia diagnosis. This space is where I share our journey as we navigate his healing through a shamanistic lens. I offer the truths we’ve discovered, the mysteries we’re still unraveling, and a critical look at a medical system that often overlooks the spiritual depth of this "dis-ease."
View all posts by Rossa Forbes
